SELLAS (SLS) is a publicly traded Healthcare sector company. As of September 17, 2026, SLS trades at $11.68 with a market cap of $2.28B and a P/E ratio of -46.06. SLS moved +3.32% today. Year to date, SLS is +209.28%; over the trailing twelve months it is +598.20%. Its 52-week range spans $0.95 to $15.88. Analyst consensus is buy with an average price target of $27.50. Rallies surfaces SLS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for SLS, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $11.68 |
| Market Cap | $2.28B |
| P/E Ratio | -46.06 |
| EPS | $-0.25 |
| Dividend Yield | 0.24% |
| 52-Week High | $15.88 |
| 52-Week Low | $0.95 |
| Volume | 4.65M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-26.86M |
| Gross Margin | 0.00% |
2 analysts cover SLS: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $27.50.